FAQ on D-Wave Quantum Inc. and Japan Tobacco's Quantum AI Project for Drug Discovery

What was the main objective of the project between D-Wave Quantum Inc. and Japan Tobacco?

The main objective was to speed up and improve the design of small molecule pharmaceuticals using quantum computing and AI, specifically by training large language models within Japan Tobacco’s AI framework.

How did the quantum-hybrid application perform compared to classical methods?

The quantum-hybrid application outperformed classical methods in generating valid and drug-like molecules, showcasing its potential to revolutionize drug discovery processes.

What technology did D-Wave provide for this project?

D-Wave provided its annealing quantum computer to enhance the training of large language models for chemical structure generation, integrated into Japan Tobacco’s drug discovery process.

What are the future plans of Japan Tobacco following this project?

Japan Tobacco plans to further pursue Quantum AI in molecular design, encouraged by the early results demonstrating the effectiveness of quantum computing in drug discovery.

Where can I find more information about D-Wave Quantum Inc.?

More information about D-Wave Quantum Inc. can be found on their website at www.dwavequantum.com and in the company’s newsroom at https://ibn.fm/QBTS.

What makes D-Wave’s quantum computers unique?

D-Wave is the world’s first commercial supplier of quantum computers and the only company building both annealing and gate-model quantum computers, with their 5,000+ qubit Advantage(TM) quantum computers being the world’s largest.

How many problems have been submitted to D-Wave’s quantum systems to date?

Over 200 million problems have been submitted to D-Wave’s Advantage and Advantage2(TM) systems, addressing use cases spanning optimization, artificial intelligence, research, and more.

What are the potential implications of this project for the pharmaceutical industry?

This project demonstrates the potential of quantum computing and AI to significantly speed up and improve the drug discovery process, potentially leading to faster development of new pharmaceuticals and treatments.